PE
Pramod Eknath Nagpure
About Pramod Eknath Nagpure
Data last updated:
Pramod Eknath Nagpure has 12 years in corporate governance. Holds Director role. Currently with 1 company, including Plant Health Biotechnologies Private Limited. Engaged in Technology. Contributes to corporate operations. The largest current company by reported revenue is Plant Health Biotechnologies Private Limited at ₹1.02 Cr (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Plant Health Biotechnologies Private Limited U24301PN2014PTC151403 | Director | 09 Jun 2014 | 2014 | ₹1.02 Cr (FY 2022) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pramod Eknath Nagpure
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pramod Eknath Nagpure
Pramod Eknath Nagpure has 12 years in corporate governance. Holds Director role. Currently with 1 company, including Plant Health Biotechnologies Private Limited. Engaged in Technology. Contributes to corporate operations. The largest current company by reported revenue is Plant Health Biotechnologies Private Limited at ₹1.02 Cr (FY 2022).
Pramod Eknath Nagpure is associated with 1 company as Director, including Plant Health Biotechnologies Private Limited (₹1.02 Cr).
Pramod Eknath Nagpure has expertise in Technology.
Pramod Eknath Nagpure has 12 years in corporate governance.
By reported revenue, the largest current company of Pramod Eknath Nagpure is Plant Health Biotechnologies Private Limited, with revenue of ₹1.02 Cr (FY 2022).
Pramod Eknath Nagpure currently holds positions at 1 company: Plant Health Biotechnologies Private Limited (₹1.02 Cr).